A groundbreaking study showed vitamin D can regulate PD-L1 levels, reducing death risk in digestive tract cancer patients by selectively using supplements based on PD-L1 levels.
Vitamin D had bimodal effects on PD-L1 levels: increased in low levels, no effect in medium levels, and decreased in high levels.
Vitamin D's potential to impact PD-L1 offers a natural, cost-effective method to enhance survival in cancer patients, potentially reducing reliance on expensive immunotherapy drugs.
[
add
]
[
|
|
...
]